2018 annual financial data

Emergent BioSolutions 2018 Net margin

Emergent BioSolutions 2018 net margin with verified reported values.

Direct answer

Net margin was 8.01%.

Operating income was 89,800,000 USD and net income was 62,700,000 USD.
Operating cash flow was 41,800,000 USD.

Get free Emergent BioSolutions email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
782,400,000 USD
Operating income
89,800,000 USD
Net income
62,700,000 USD
Operating cash flow
41,800,000 USD